hydrogen carbonate has been researched along with natriuretic peptide, brain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Grady, SM; Traynor, TR | 1 |
| Cantelli, S; Catizone, L; Fabbian, F; Molino, C; Russo, G; Russo, M; Sartori, S; Stabellini, N | 1 |
| Criley, J; Darwish, OS | 1 |
| Alharethi, R; Bair, TL; Benuzillo, J; Bradshaw, A; Budge, D; Cantu, G; Horne, BD; James, BC; Kfoury, AG; Lappé, DL; Masica, AL; McCubrey, RO; Rasmusson, KD; Roberts, CA; Savitz, LA | 1 |
4 other study(ies) available for hydrogen carbonate and natriuretic peptide, brain
| Article | Year |
|---|---|
Brain natriuretic peptide stimulates K and Cl secretion across porcine distal colon epithelium.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Bicarbonates; Chlorides; Colon; Epithelium; In Vitro Techniques; Kinetics; Molecular Sequence Data; Muscle, Smooth; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Potassium; Rats; Sequence Homology, Nucleic Acid; Swine | 1991 |
Role of B-type natriuretic peptide in cardiovascular state monitoring in a hemodialysis patient with primary amyloidosis.
Topics: Amyloidosis; Anti-Inflammatory Agents; Bicarbonates; Buffers; Cardiac Output, Low; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Melphalan; Middle Aged; Natriuretic Peptide, Brain; Nephrotic Syndrome; Prednisolone; Renal Dialysis; Thalidomide; Treatment Outcome | 2006 |
Hydrochlorothiazide-induced noncardiogenic pulmonary edema: BAL fluid analysis.
Topics: Bicarbonates; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Diuretics; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Lactic Acid; Leukocyte Count; Middle Aged; Natriuretic Peptide, Brain; Neutrophils; Pulmonary Edema; Severity of Illness Index; Tomography, Spiral Computed | 2011 |
Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Bicarbonates; Blood Urea Nitrogen; Calcium Channel Blockers; Cardiotonic Agents; Creatinine; Diuretics; Erythrocyte Count; Erythrocyte Indices; Heart Failure; Hematocrit; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Leukocyte Count; Logistic Models; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Odds Ratio; Patient Readmission; Platelet Aggregation Inhibitors; Potassium; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Factors; Sodium; Vasoconstrictor Agents; Young Adult | 2017 |